iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Lcnb Corp

Lcnb Corp lowered its position in iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 16.1% in the fourth quarter, HoldingsChannel reports. The fund owned 1,870 shares of the financial services provider’s stock after selling 360 shares during the quarter. Lcnb Corp’s holdings in iShares Biotechnology ETF were worth $254,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. Glass Jacobson Investment Advisors llc grew its stake in iShares Biotechnology ETF by 150.6% in the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 122 shares during the period. Crewe Advisors LLC grew its position in shares of iShares Biotechnology ETF by 42.9% in the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 78 shares during the period. Northwest Financial Advisors acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $42,000. Values First Advisors Inc. purchased a new stake in iShares Biotechnology ETF during the 4th quarter worth approximately $43,000. Finally, Tennessee Valley Asset Management Partners acquired a new position in iShares Biotechnology ETF in the 4th quarter valued at $44,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB traded up $0.84 during mid-day trading on Thursday, reaching $133.35. The company’s stock had a trading volume of 1,923,517 shares, compared to its average volume of 1,731,144. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16. The stock has a 50-day moving average of $132.56 and a two-hundred day moving average of $132.40.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were issued a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.38%.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Stories

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBFree Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.